4//SEC Filing
Pellegrini Niamh Louise 4
Accession 0001567619-21-003621
CIK 0001444380other
Filed
Feb 11, 7:00 PM ET
Accepted
Feb 12, 5:29 PM ET
Size
8.8 KB
Accession
0001567619-21-003621
Insider Transaction Report
Form 4
NEVRO CORPNVRO
Pellegrini Niamh Louise
Chief Commercial Officer
Transactions
- Sale
Common Stock
2021-02-10$182.55/sh−750$136,913→ 30,328 total - Exercise/Conversion
Common Stock
2021-02-10$64.95/sh+750$48,713→ 31,078 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-02-10−750→ 66,325 totalExercise: $64.95Exp: 2029-07-14→ Common Stock (750 underlying)
Footnotes (3)
- [F1]The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
- [F2]Includes 30,328 restricted stock units.
- [F3]25% of the shares subject to the option vest on the first anniversary measured from July 15, 2019 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest in thirty-six (36) successive and equal monthly installments thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
Documents
Issuer
NEVRO CORP
CIK 0001444380
Entity typeother
Related Parties
1- filerCIK 0001620611
Filing Metadata
- Form type
- 4
- Filed
- Feb 11, 7:00 PM ET
- Accepted
- Feb 12, 5:29 PM ET
- Size
- 8.8 KB